Thrombocytopenia: Difference between revisions
From IDWiki
mNo edit summary |
(added some drugs) |
||
| Line 7: | Line 7: | ||
**[[Immune-mediated thrombocytopenic purpura]] (ITP) |
**[[Immune-mediated thrombocytopenic purpura]] (ITP) |
||
***[[Hepatitis C]], [[HIV]], and [[Helicobacter pylori]] |
***[[Hepatitis C]], [[HIV]], and [[Helicobacter pylori]] |
||
***Medications |
|||
****More likely: [[abciximab]], beta-lactams (including [[penicillins]] and [[cephalosporins]]), [[carbamazepine]], [[epifitabide]], gold compounds, [[Heparin-inducted thrombocytopenia|heparin]], [[linezolid]], MMR vaccine, [[phenytoin]], [[piperacillin]], [[quinidine]], [[quinine]], [[rifampin]], sulfonamides (including [[TMP-SMX]]), [[valproic acid]], and [[vancomycin]] |
|||
**[[Thrombotic microangiopathy]] |
**[[Thrombotic microangiopathy]] |
||
***[[TTP]]/[[HUS]], other TMAs |
***[[TTP]]/[[HUS]], other TMAs |
||
Revision as of 14:51, 20 September 2022
Differential Diagnosis
- Decreased production
- Viral infection
- Malignancy
- Destruction/Consumption
- Immune-mediated thrombocytopenic purpura (ITP)
- Hepatitis C, HIV, and Helicobacter pylori
- Medications
- More likely: abciximab, beta-lactams (including penicillins and cephalosporins), carbamazepine, epifitabide, gold compounds, heparin, linezolid, MMR vaccine, phenytoin, piperacillin, quinidine, quinine, rifampin, sulfonamides (including TMP-SMX), valproic acid, and vancomycin
- Thrombotic microangiopathy
- Immune-mediated thrombocytopenic purpura (ITP)
- Sequestration
Investigations
- Rule out secondary causes with hepatitis C virus, HIV, and Helicobacter pylori serology
